Literature DB >> 12892839

Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes.

Anne-Marie Bleau1, Patrick Maurel, Vincent Pichette, François Leblond, Patrick du Souich.   

Abstract

Inflammation reduces activity and expression of hepatic cytochrome P450 (P450) and therefore diminishes drug biotransformation. This study aimed to identify the serum mediators triggered by a viral infection and an aseptic inflammation that downregulate P450 isoforms. Incubation of hepatocytes with serum from rabbits with a turpentine-induced inflammation or humans with a viral infection decreased the amount of cytochrome 1A1 (CYP1A1), 1A2 and 3A6 mRNA and apoproteins. By serum fractionation and immuno-neutralization, we showed that in the aseptic inflammation, interleukin-6 and, to a lesser degree, interleukin-1beta are involved in the downregulation of all three isoforms. In serum from humans with a viral infection, interleukin-1beta, interleukin-6, interferon-gamma and tumour necrosis factor-alpha contribute to the downregulation of P450 isoforms. CYP1A1 and 1A2 are regulated by serum mediators at the transcriptional level, while the expression of CYP3A6 appears to be under the control of pre- and posttranscriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892839     DOI: 10.1016/s0014-2999(03)01968-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  The influence of cytochrome P450 pharmacogenetics on disposition of common antidepressant and antipsychotic medications.

Authors:  Jan van der Weide; John W J Hinrichs
Journal:  Clin Biochem Rev       Date:  2006-02

3.  Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain.

Authors:  Denis Projean; Sophie Dautrey; Huy Khan Vu; Thierry Groblewski; Jean-Louis Brazier; Julie Ducharme
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

4.  Involvement of CYP1B1 in interferon γ-induced alterations of epithelial barrier integrity.

Authors:  Mireille Alhouayek; Sandra Gouveia-Figueira; Marie-Louise Hammarström; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2018-02-04       Impact factor: 8.739

5.  Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3.

Authors:  Amir A Ghaffari; Edward K Chow; Shankar S Iyer; Jane C Deng; Genhong Cheng
Journal:  Hepatology       Date:  2011-06       Impact factor: 17.425

6.  Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.

Authors:  Géraldine Pettersen; Mohamad-Samer Mouksassi; Yves Théorêt; Line Labbé; Christophe Faure; Bao Nguyen; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2008-10-23       Impact factor: 4.335

7.  TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.

Authors:  Colin M North; Byung-Sam Kim; Neil Snyder; Robert B Crawford; Michael P Holsapple; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2008-10-22       Impact factor: 4.849

8.  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

Authors:  Sylvie M Mimche; Beatrice A Nyagode; Matthew D Merrell; Choon-Myung Lee; Nina S Prasanphanich; Richard D Cummings; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-10-25       Impact factor: 3.922

9.  Gender differences in murine pulmonary responses elicited by cellulose nanocrystals.

Authors:  Anna A Shvedova; Elena R Kisin; Naveena Yanamala; Mariana T Farcas; Autumn L Menas; Andrew Williams; Philip M Fournier; Jeffrey S Reynolds; Dmitriy W Gutkin; Alexander Star; Richard S Reiner; Sabina Halappanavar; Valerian E Kagan
Journal:  Part Fibre Toxicol       Date:  2016-06-08       Impact factor: 9.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.